Navigation Links
New wonder drug could treat blindness

Swiss drug maker Novartis has developed a drug that could treat blindness by combating the wet form of a condition called age-related// macular degeneration (AMD).

AMD usually affects people above 60 years of age and the wet form progresses quickly and can cause blindness.

The drug called Lucentis was tried on 716 patients in the US who received monthly injections of the drug into the affected eye over a two-year period.

One-third experienced a "marked improvement" in vision, enabling them to read more lines on an eye chart than before and return to abandoned hobbies, reported the online edition of Daily mail.

It is the first time a treatment for wet AMD has been found to significantly improve vision in large-scale clinical trials, said the study published in the New England Journal of Medicine.

Lucentis targets abnormal blood vessels that grow behind the eyeball. These vessels can leak and cause damage to parts of the eye responsible for central vision.

The drug, which is also known by its generic name Ranibizumab, has not yet been priced in Britain.

But in the US it costs around $2,000 a treatment. The drug is due to be licensed in Britain by the end of the year.

Source-IANS
'"/>




Page: 1

Related medicine news :

1. Butterbur does wonders
2. Cancer wonder drug will not be a slip between the cup and the lip!
3. Virus Level could Predict Cervical Cancer Risk
4. Beware of the oral patch! It could be cancer!!!
5. Prozac miracle could end in disaster
6. Wonder drug - could end in disaster
7. Pollution could be a risk
8. Fright could be more harmful
9. Pregnant smokers could harm their child
10. Snoring could be a warning
11. Anthrax drug doxycycline could stunt fetal growth
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New wonder drug could treat blindness

(Date:8/29/2008)..., Aug. 29 /PRNewswire-USNewswire/ -- The Custom Br...oday the launch of the Endocrine,Daily Briefing, p...ious,Endocrine Society., Endocrine Daily Briefing...ndocrine Society members, medical professionals en...es and osteoporosis. Endocrine Daily,Briefing join...
(Date:8/29/2008)...ses of wine enough to disrupt normal development, ...ealthDay News) -- Just a few glasses of wine over ...problems, suggest researchers from the Medical Col...alcohol syndrome, which affects one in 1,000 babie... high upper lip, small eye openings, and a short n...
(Date:8/29/2008)...ll., Aug. 29 /PRNewswire-FirstCall/ -- Landauer, I...Directors declared a regular,quarterly cash divide...scal,2008. The dividend will be paid on October 3,...2008., About Landauer, Landauer is the leading p...tional and environmental radiation exposure. For m...
(Date:8/29/2008)... AMD presents Telemedicine Encounter Man...d State delegations as a possible solution to nati... N.Chelmsford, MA (PRWEB) August 29, 2008 -- If... by the speakers at the Democratic National Conven...resolve our national health care issues., , ,Our D...
Breaking Medicine News(10 mins):Health News:Custom Briefings Announces Launch of Endocrine Daily Briefing 2Health News:Alcohol in Early Pregnancy May Prompt Fetal Cell Death 2Health News:AMD Global Telemedicine Inc. Invited to Attend Democratic National Convention 2
... quality has resulted in increasing number of chil...// The deterioration of Hong Kong’s air quality ...tted to hospital with breathing problems. Re...iversity have found that a rise in pollutants such...
...that throwing raw eggs at people either in protest... eye injury.// The study has been published in t...grave eye injuries could result from lobbing raw e... the Royal Liverpool University Hospital studied o...
...f researchers to unravel the potential of the brai... to the origin of response to// fear, is a specifi...t at the end of the tunnel for those in the throes... Scientists used a fairly easy examination along...
...ing music acquire better memories, literacy skills...ts. This study was conducted by// Laurel Trainor, ... at McMaster University in Hamilton, Ontario and h...of 6 children aged 4-6. They took a music test aft...
Other Medicine News:Health News:Fearful or Fearless, Control Exists in The Brain 2
(Date:8/27/2008)...n Memorial Hospital one of 18 centers involved in ...swire/ -- Results of a 10-year study,published in ...Medicine,found that magnesium sulfate administered...reduced the risk of cerebral palsy by 50 percent. ...ate (BEAM) trial was,conducted in 18 centers in th...
(Date:8/27/2008)...France, August 27 /-, - Or...sults in a,Pharmacodynamic Study Conducted in an A...unces the highly positive results of a new study,c... The study on Oralair(R) Grasses included 86 adult...ifferent treatment durations: 1 week, 1 month,2 a...
(Date:8/26/2008)...re., Aug. 26 /- The Oregon Tourism Co... Customer Service Training Program,(Q Care) this w...re is a training program created to support the to...ployee education. By emphasizing,the importance of...,employees with tools and resources to better serv...
(Date:8/26/2008)...OLIS, Aug. 26 /- Semafore Pharmaceuti...nal Congress on Targeted Therapies,in Cancer in Wa...multi-targeted kinase inhibitors that demonstrate ...dies., A novel and proprietary molecular scaffold...llowing for the design of pan-PI3 kinase inhibitor...
Breaking Medicine Technology:National Study Shows Magnesium Sulfate Reduces Risk of Cerebral Palsy in Premature Births 2National Study Shows Magnesium Sulfate Reduces Risk of Cerebral Palsy in Premature Births 3Stallergenes: New Study VO 56 Highly Positive Results Conducted in an Allergen Challenge Chamber 2Stallergenes: New Study VO 56 Highly Positive Results Conducted in an Allergen Challenge Chamber 3Oregon Tourism Commission Unveils New Online Customer Service Training Program 2Semafore Broadens Pipeline With Multi-Targeted Kinase Inhibitors 2Semafore Broadens Pipeline With Multi-Targeted Kinase Inhibitors 3ADVENTRX Pharmaceuticals to Present at the 2007 BIOInvestor Forum 1100 1ADVENTRX Pharmaceuticals to Present at the 2007 BIOInvestor Forum 1100 2Mouse Study Gives Clues to Colitis 3033 1Mouse Study Gives Clues to Colitis 3033 2Monsanto Company Sets Webcast and Analyst Media Call for 2007 Fourth Quarter and Fiscal Year Financial Results 1099 1Monsanto Company Sets Webcast and Analyst Media Call for 2007 Fourth Quarter and Fiscal Year Financial Results 1099 2Researchers complete first clinical trial of Apatone for cancer treatment 3029 1Researchers complete first clinical trial of Apatone for cancer treatment 3029 2Researchers complete first clinical trial of Apatone for cancer treatment 3029 3
...AVI BioPharma, Inc.,(Nasdaq:AVII) announced today ... patient enrollment and released six-month,follow-...praisal.,The trial, currently being held in German...(R) antisense drug Resten-MP(TM), when,used in con...tal,stents, in the prevention of cardiovascular re...
... Adjusted Weight,Loss; Obesity Program to be Disco...Call/ -- Manhattan,Pharmaceuticals, Inc. today ann...cal trials of oral Oleoyl-estrone (OE). The result...lled studies, one,in common obesity and the other ...r clinically meaningful placebo adjusted weight lo...
Other Medicine Technology:AVI BioPharma Partner Cook Medical Announces Completion of Patient,Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of,Cardiovascular Disease 2Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for,Oral Oleoyl-estrone 2Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for,Oral Oleoyl-estrone 3Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for,Oral Oleoyl-estrone 4
Fully lined with cotton material for extra softness against patients skin. The 3 double adjustable soft Velcro® bands provide vertical/downward pressure for adjustable comfort following submuscu
Velcro® closure, uniform contour compression, available as 9" and 12" bands for abdominal support, 9" can be used as a breast wrap.
Sub Pectoral Bra
Sub Pectoral Breast Augmentation Wrap
Medicine Products: